These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38944496)

  • 1. Management of Poorly Differentiated Thyroid Cancer and Differentiated High-Grade Thyroid Carcinoma.
    Alam IS; Patel KN
    Surg Clin North Am; 2024 Aug; 104(4):751-765. PubMed ID: 38944496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
    Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
    Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas.
    Cracolici V; Cipriani NA
    Endocr Pathol; 2023 Mar; 34(1):34-47. PubMed ID: 36692728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
    Raue F; Frank-Raue K
    Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interpretation of the pathological diagnostic criteria and characteristics of high-grade thyroid follicular-derived carcinoma in the 5
    Zhou J; Liu ZY
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1578-1583. PubMed ID: 38742344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
    Filetti S; Durante C; Hartl D; Leboulleux S; Locati LD; Newbold K; Papotti MG; Berruti A;
    Ann Oncol; 2019 Dec; 30(12):1856-1883. PubMed ID: 31549998
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytologic features of aggressive variants of follicular-derived thyroid carcinoma.
    Rossi ED; Faquin WC; Pantanowitz L
    Cancer Cytopathol; 2019 Jul; 127(7):432-446. PubMed ID: 31150164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyroid gland carcinoma].
    Schmid KW
    Praxis (Bern 1994); 1998 Mar; 87(11):367-74. PubMed ID: 9562812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic classification of thyroid follicular cell tumors using Ki-67 labeling index: risk stratification of thyroid follicular cell carcinomas.
    Kakudo K; Wakasa T; Ohta Y; Yane K; Ito Y; Yamashita H
    Endocr J; 2015; 62(1):1-12. PubMed ID: 25195708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin.
    Fallahi P; Ferrari SM; Elia G; Ragusa F; Patrizio A; Paparo SR; Marone G; Galdiero MR; Guglielmi G; Foddis R; Cristaudo A; Antonelli A
    Semin Cancer Biol; 2022 Feb; 79():203-216. PubMed ID: 32569821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
    Lubitz CC; Sadow PM; Daniels GH; Wirth LJ
    Thyroid; 2021 Oct; 31(10):1451-1462. PubMed ID: 33860688
    [No Abstract]   [Full Text] [Related]  

  • 12. Well-differentiated carcinoma of the thyroid.
    Boone RT; Fan CY; Hanna EY
    Otolaryngol Clin North Am; 2003 Feb; 36(1):73-90, viii. PubMed ID: 12803010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
    Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
    Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of locally aggressive well-differentiated thyroid cancer.
    Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
    Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poorly differentiated thyroid carcinomas: conceptual controversy and clinical impact.
    Coca-Pelaz A; Rodrigo JP; Agaimy A; Williams MD; Saba NF; Nuyts S; Randolph GW; López F; Vander Poorten V; Kowalski LP; Civantos FJ; Zafereo ME; Mäkitie AA; Cohen O; Nixon IJ; Rinaldo A; Ferlito A
    Virchows Arch; 2024 May; 484(5):733-742. PubMed ID: 38400843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of differentiated thyroid cancer of the follicular epithelium.
    Pacini F
    Ann Med; 2012 Nov; 44(7):651-5. PubMed ID: 21668295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular thyroid carcinoma: From diagnosis to treatment.
    Lin JD; Chao TC
    Endocr J; 2006 Aug; 53(4):441-8. PubMed ID: 16807500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
    Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
    Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
    Haddad RI; Bischoff L; Ball D; Bernet V; Blomain E; Busaidy NL; Campbell M; Dickson P; Duh QY; Ehya H; Goldner WS; Guo T; Haymart M; Holt S; Hunt JP; Iagaru A; Kandeel F; Lamonica DM; Mandel S; Markovina S; McIver B; Raeburn CD; Rezaee R; Ridge JA; Roth MY; Scheri RP; Shah JP; Sipos JA; Sippel R; Sturgeon C; Wang TN; Wirth LJ; Wong RJ; Yeh M; Cassara CJ; Darlow S
    J Natl Compr Canc Netw; 2022 Aug; 20(8):925-951. PubMed ID: 35948029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.
    Amacher AM; Goyal B; Lewis JS; El-Mofty SK; Chernock RD
    Am J Surg Pathol; 2015 Feb; 39(2):260-5. PubMed ID: 25321328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.